Skip to main content

Lung

Ausgabe 2/2013

Inhalt (10 Artikel)

Safety and Efficacy of 12-Week or Longer Indacaterol Treatment in Moderate-to-Severe COPD Patients: A Systematic Review

Fa-Ming Jiang, Zong-An Liang, Qiao-Ling Zheng, Rong-Chun Wang, Jian Luo, Chun-Tao Li

Therapeutic Potential of Growth Factors in Pulmonary Emphysematous Condition

Jai Prakash Muyal, Vandana Muyal, Sudhir Kotnala, Dhananjay Kumar, Harsh Bhardwaj

Dynamic Hyperinflation Correlates with Exertional Oxygen Desaturation in Patients with Chronic Obstructive Pulmonary Disease

Muhammad Ahsan Zafar, Wayne Tsuang, Laura Lach, William Eschenbacher, Ralph J. Panos

A Possible Role of Galectin-9 in the Pulmonary Fibrosis of Patients with Interstitial Pneumonia

Nobuhiro Matsumoto, Shigeki Katoh, Shigehisa Yanagi, Yasuji Arimura, Masatoshi Tokojima, Masaki Ueno, Mitsuomi Hirashima, Masamitsu Nakazato

TGF-β1 T869C Polymorphism May Affect Susceptibility to Idiopathic Pulmonary Fibrosis and Disease Severity

Ji Young Son, Song Yee Kim, Sang Ho Cho, Hyo Sub Shim, Ji-Ye Jung, Eun Young Kim, Ju Eun Lim, Byung Hoon Park, Young Ae Kang, Young Sam Kim, Se Kyu Kim, Joon Chang, Moo Suk Park

Tumor Necrosis Factor-α Plays an Initiating Role in Extracorporeal Circulation-induced Acute Lung Injury

Tao Li, Nanfu Luo, Lei Du, Jing Zhou, Jie Zhang, Lina Gong, Nenggang Jiang

Aktuelle Ausgaben

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.